The FDA has approved a dihydroergotamine-based nasal powder for the acute treatment of migraine with or without aura in ...

DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the nasal powder formulation, ...

Adult and pediatric generalized myasthenia gravis patients have a new, longer acting option for treatment called Imaavy.

New Delhi: MSN Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to manufacture and market Lurasidone ...

Journal of Nuclear Medicine April 2025, jnumed.124.268961; DOI: https://doi.org/10.2967/jnumed.124.268961 ...